大塚ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/08/26 | 4,597 | 4,633 | 4,588 | 4,601 | +8 | +0.2% | 463,700 |
| 2022/08/25 | 4,605 | 4,619 | 4,567 | 4,593 | +8 | +0.2% | 621,600 |
| 2022/08/24 | 4,604 | 4,614 | 4,557 | 4,585 | -68 | -1.5% | 730,600 |
| 2022/08/23 | 4,724 | 4,728 | 4,633 | 4,653 | -87 | -1.8% | 906,400 |
| 2022/08/22 | 4,709 | 4,753 | 4,654 | 4,740 | +73 | +1.6% | 861,100 |
| 2022/08/19 | 4,705 | 4,715 | 4,662 | 4,667 | -46 | -1% | 730,100 |
| 2022/08/18 | 4,713 | 4,722 | 4,664 | 4,713 | -6 | -0.1% | 1,138,300 |
| 2022/08/17 | 4,668 | 4,732 | 4,650 | 4,719 | +25 | +0.5% | 1,018,600 |
| 2022/08/16 | 4,713 | 4,722 | 4,662 | 4,694 | -32 | -0.7% | 656,200 |
| 2022/08/15 | 4,685 | 4,740 | 4,682 | 4,726 | +38 | +0.8% | 563,900 |
| 2022/08/12 | 4,689 | 4,716 | 4,665 | 4,688 | +69 | +1.5% | 1,293,700 |
| 2022/08/10 | 4,655 | 4,670 | 4,582 | 4,619 | -25 | -0.5% | 1,019,000 |
| 2022/08/09 | 4,677 | 4,708 | 4,628 | 4,644 | -36 | -0.8% | 841,000 |
| 2022/08/08 | 4,635 | 4,693 | 4,622 | 4,680 | +21 | +0.5% | 744,800 |
| 2022/08/05 | 4,611 | 4,664 | 4,600 | 4,659 | +70 | +1.5% | 1,188,800 |
| 2022/08/04 | 4,719 | 4,719 | 4,554 | 4,589 | +10 | +0.2% | 1,239,400 |
| 2022/08/03 | 4,648 | 4,648 | 4,562 | 4,579 | +24 | +0.5% | 1,265,200 |
| 2022/08/02 | 4,670 | 4,681 | 4,550 | 4,555 | -183 | -3.9% | 1,045,800 |
| 2022/08/01 | 4,722 | 4,770 | 4,711 | 4,738 | -16 | -0.3% | 1,013,300 |
| 2022/07/29 | 4,944 | 4,948 | 4,691 | 4,754 | -149 | -3% | 1,710,200 |
| 2022/07/28 | 4,899 | 4,920 | 4,826 | 4,903 | +7 | +0.1% | 1,241,900 |
| 2022/07/27 | 4,866 | 4,913 | 4,786 | 4,896 | +9 | +0.2% | 1,530,800 |
| 2022/07/26 | 4,942 | 4,958 | 4,876 | 4,887 | -69 | -1.4% | 792,900 |
| 2022/07/25 | 4,955 | 4,990 | 4,923 | 4,956 | +4 | +0.1% | 665,100 |
| 2022/07/22 | 4,976 | 4,983 | 4,900 | 4,952 | -26 | -0.5% | 797,300 |
| 2022/07/21 | 4,902 | 4,987 | 4,899 | 4,978 | +39 | +0.8% | 840,900 |
| 2022/07/20 | 4,906 | 4,949 | 4,879 | 4,939 | +76 | +1.6% | 955,300 |
| 2022/07/19 | 4,902 | 4,914 | 4,838 | 4,863 | -54 | -1.1% | 645,500 |
| 2022/07/15 | 4,941 | 4,966 | 4,898 | 4,917 | -21 | -0.4% | 866,000 |
| 2022/07/14 | 4,910 | 4,960 | 4,875 | 4,938 | +10 | +0.2% | 915,300 |
| 2022/07/13 | 4,937 | 4,976 | 4,915 | 4,928 | -18 | -0.4% | 809,400 |
| 2022/07/12 | 4,954 | 4,985 | 4,924 | 4,946 | -38 | -0.8% | 1,058,400 |
| 2022/07/11 | 4,949 | 5,000 | 4,920 | 4,984 | +105 | +2.2% | 1,163,900 |
| 2022/07/08 | 4,950 | 4,962 | 4,832 | 4,879 | -121 | -2.4% | 1,593,500 |
| 2022/07/07 | 4,972 | 5,000 | 4,923 | 5,000 | +65 | +1.3% | 1,391,000 |
| 2022/07/06 | 4,867 | 4,964 | 4,860 | 4,935 | +39 | +0.8% | 1,508,200 |
| 2022/07/05 | 4,881 | 4,896 | 4,830 | 4,896 | +14 | +0.3% | 1,055,000 |
| 2022/07/04 | 4,900 | 4,929 | 4,840 | 4,882 | +113 | +2.4% | 1,104,400 |
| 2022/07/01 | 4,858 | 4,904 | 4,753 | 4,769 | -49 | -1% | 1,080,500 |
| 2022/06/30 | 4,815 | 4,861 | 4,811 | 4,818 | +13 | +0.3% | 1,439,500 |
| 2022/06/29 | 4,850 | 4,878 | 4,793 | 4,805 | -130 | -2.6% | 1,703,800 |
| 2022/06/28 | 4,809 | 4,950 | 4,797 | 4,935 | +138 | +2.9% | 1,611,700 |
| 2022/06/27 | 4,567 | 4,805 | 4,518 | 4,797 | +245 | +5.4% | 2,104,900 |
| 2022/06/24 | 4,560 | 4,565 | 4,499 | 4,552 | +27 | +0.6% | 702,600 |
| 2022/06/23 | 4,490 | 4,554 | 4,490 | 4,525 | +30 | +0.7% | 754,300 |
| 2022/06/22 | 4,465 | 4,517 | 4,453 | 4,495 | +59 | +1.3% | 735,100 |
| 2022/06/21 | 4,430 | 4,462 | 4,379 | 4,436 | +29 | +0.7% | 904,200 |
| 2022/06/20 | 4,413 | 4,447 | 4,380 | 4,407 | +47 | +1.1% | 552,200 |
| 2022/06/17 | 4,322 | 4,388 | 4,307 | 4,360 | ±0 | ±0% | 1,339,700 |
| 2022/06/16 | 4,378 | 4,415 | 4,358 | 4,360 | +49 | +1.1% | 704,000 |
551～
600
件表示中 / 3412件
類似銘柄と比較する
現在ご覧いただいている「大塚ＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大塚ＨＤ | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| 第一三共 | 443,500円 | +14.3% | +20.1% | 1.35% | 37.27倍 | 5.17倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 411,300円 | +5.1% | +76.2% | 4.77% | 95.87倍 | 0.94倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム
